Search results
Showing results for
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
New model for infant leukaemia announced
25 November 2021
The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
Study reveals ‘stop-eating’ response to DNA damage
24 November 2021
A new study from the Patel Group sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.
$2m awarded to explore the role of ancestry in vaccine response
17 November 2021
The Lymph nodE single-cell Genomics AnCestrY (LEGACY) Network will create an ethnically diverse single-cell atlas of the response to commonly used vaccines such as flu vaccines with a focus on responses in lymph nodes.
New scholarship announced to support leukaemia research
3 November 2021
The ‘Oxford-Kay Kendall Leukaemia Fund Graduate Scholarship’ based at the MRC WIMM, will commence in 2023.
Focus on racism- making a difference for sickle cell disease
27 October 2021
Project aims to increase understanding, reduce stigma, and improve the quality of life of people living with sickle cell disease.
‘Most Impactful Paper’ award for ovarian cancer research
27 October 2021
MRC WIMM researchers receive award hosted by the Columbia Hospital for Women Research Foundation
Giulia Orlando becomes a John Goldman Fellow
19 October 2021
Many congratulations to Dr Giulia Orlando, who has become a 2021 Leukaemia UK John Goldman Fellow.
Join us at the IF Science and Ideas Festival
12 October 2021
Come down to Templars Shopping Centre on 23rd or 24th October 2021 for ‘Science at the Shops’ as part of IF Oxford Science and Ideas Festival.
Blood tests may predict response to immunotherapy for melanoma
4 October 2021
A study from the Fairfax lab provides new insight into the factors that determine patient response to Immune Checkpoint Blockers, a common immunotherapy treatment for melanoma.
Hashem Koohy receives Turing Fellowship
1 October 2021
Fellows are established scholars with proven research excellence in data science, artificial intelligence (AI), or a related field.
New atlas revealed of bone marrow haematopoiesis during development
29 September 2021
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Changes in blood cell production over the human lifetime may hold clues to patterns of disease
16 September 2021
A new paper published in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.
New Associate Professor appointments announced
10 September 2021
Congratulations to Dr Bethan Psaila, Dr Benjamin Fairfax, Dr Hashem Koohy, Dr Andrew Blackford and Dr Oliver Bannard who have all been awarded the title of Associate Professor in recognition of their research achievements, contribution to teaching and contributions to the Medical Sciences Division.
Mechanism behind repair of cancer-inducing mutations discovered
28 July 2021
New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.